In This Article:
The Australian market has recently seen the ASX200 reach a new all-time intra-day high, driven by strong performances in Health Care, Financials, and Utilities sectors. Amid these developments, investors might find opportunities in penny stocks—smaller or newer companies that can offer unexpected value. While the term "penny stock" may seem outdated, it still captures the essence of investing in lesser-known firms with solid financial foundations and potential for growth.
Top 10 Penny Stocks In Australia
Name | Share Price | Market Cap | Financial Health Rating |
Embark Early Education (ASX:EVO) | A$0.79 | A$144.95M | ★★★★☆☆ |
LaserBond (ASX:LBL) | A$0.565 | A$66.23M | ★★★★★★ |
Helloworld Travel (ASX:HLO) | A$2.01 | A$327.26M | ★★★★★★ |
Austin Engineering (ASX:ANG) | A$0.525 | A$325.58M | ★★★★★☆ |
EZZ Life Science Holdings (ASX:EZZ) | A$2.50 | A$111.06M | ★★★★★★ |
SHAPE Australia (ASX:SHA) | A$2.77 | A$229.66M | ★★★★★★ |
Navigator Global Investments (ASX:NGI) | A$1.64 | A$803.73M | ★★★★★☆ |
Atlas Pearls (ASX:ATP) | A$0.15 | A$65.35M | ★★★★★★ |
Vita Life Sciences (ASX:VLS) | A$2.075 | A$116.81M | ★★★★★★ |
Servcorp (ASX:SRV) | A$4.97 | A$490.37M | ★★★★☆☆ |
Click here to see the full list of 1,045 stocks from our ASX Penny Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Clover
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Clover Corporation Limited produces, refines, and sells natural oils and encapsulated powders across multiple regions including Australia, New Zealand, Asia, Europe, the Middle East, and the Americas; it has a market cap of A$80.99 million.
Operations: The company generates revenue of A$62.21 million from its Nutritional Oil and Microencapsulated Powders segment.
Market Cap: A$80.99M
Clover Corporation Limited, with a market cap of A$80.99 million, is an intriguing option in the penny stock space due to its significant presence across multiple regions and revenue generation of A$62.21 million from its Nutritional Oil and Microencapsulated Powders segment. Despite facing challenges with declining earnings and profit margins over the past year, Clover maintains strong financial health, evidenced by a reduced debt-to-equity ratio and sufficient short-term assets to cover liabilities. The company's management team is experienced, though its return on equity remains low at 2.3%. Earnings are forecasted to grow significantly in the future.
-
Click here to discover the nuances of Clover with our detailed analytical financial health report.
-
Assess Clover's future earnings estimates with our detailed growth reports.
EVZ
Simply Wall St Financial Health Rating: ★★★★★★
Overview: EVZ Limited, with a market cap of A$19.42 million, operates in the engineering services sectors across Australia and Asia through its subsidiaries.